Literature DB >> 7910234

Sudden hearing loss associated with interferon.

Y Kanda1, K Shigeno, N Kinoshita, K Nakao, M Yano, H Matsuo.   

Abstract

With the increasing long-term use of interferon, several new adverse effects have been recognised. We have prospectively assessed auditory function in 49 patients receiving interferon, after we saw a case of sudden sensorineural hearing loss during interferon therapy. Auditory disability (tinnitus, hearing loss, or both) occurred in 22 patients (45%) during treatment with audiometry-documented sensorineural hearing loss in 18 (37%). The auditory disability often developed in the late stage of treatment and resolved in all patients within 7-14 days after discontinuation of interferon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910234     DOI: 10.1016/s0140-6736(94)90237-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

3.  Cochlear implantation in deaf patients with eosinophilic otitis media using subtotal petrosectomy and mastoid obliteration.

Authors:  Hisashi Sugimoto; Miyako Hatano; Masao Noda; Hiroki Hasegawa; Tomokazu Yoshizaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-11       Impact factor: 2.503

4.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

5.  Effect of interferon treatment on hearing of patients with chronic hepatitis C.

Authors:  Abdulrahman Hagr; Dima Jamjoom; Faisal M Sanai; Waleed Al Hamoudi; Ayman A Abdo; Ahmed Al-Arfaj
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

6.  Alpha-Interferon for the treatment of idiopathic sudden sensorineural hearing loss.

Authors:  S Kanemaru; H Fukushima; H Nakamura; H Tamaki; Y Fukuyama; Y Tamura
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 7.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

8.  Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment.

Authors:  Hela Elloumi; Fatma Houissa; Najet-Bel Hadj; Dalila Gargouri; Malika Romani; Jamel Kharrat; Abdeljabbar Ghorbel
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 9.  Biotherapy of chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; F Schneller; C Huber
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

10.  INF- α and ototoxicity.

Authors:  Mohammad Reza Sharifian; Shima Kamandi; Hamid Reza Sima; Mohammad Ali Zaringhalam; Mehdi Bakhshaee
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.